Markham C. Luke, MD, PhD, FAAD
Physician, Reviewer, Supervisor, FDA
Markham C. Luke, MD, PhD, FAAD is listed as Physician, Reviewer, Supervisor, FDA. Markham is scheduled to speak at American Academy of Dermatology Annual Meeting 2027 on 19 March 2027.
Compiled from published conference agendas; not yet confirmed by Markham. Is this you? Claim this profile.
About
Dr. Markham C. Luke, MD, PhD, FAAD is a board-certified dermatologist and regulatory leader who serves as Supervisory Physician and the Director of the Division of Therapeutic Performance within the Office of Generic Drugs (OGD) at the U.S. Food and Drug Administration (FDA). Since joining the FDA in 1998, he has served in various roles including leading review teams for new drugs for dermatology, providing clinical supervision for the review office in the Center for Devices and Radiological Health, directing FDA cosmetics regulation, and providing leadership for regulatory science research initiatives to establish bioequivalence standards for complex generic drugs and drug-device combination products. Alongside his regulatory work, Dr. Luke maintained ties to clinical practice and academia as a Clinical Consultant in Dermatology at the National Institutes of Health (NIH) and as an Adjunct Associate Professor of Dermatology at the Uniformed Services University. He holds both an MD and
Upcoming
American Academy of Dermatology Annual Meeting 2027 19 March 2027 – 23 March 2027
- FDA Forum: The Dermatology Drug Product Life Cycle - IND to NDA to ANDA Chair · 19 March 2027
Spoke alongside
People who have shared a session with Markham at events on B2DB.
- Elizabeth Rizza, MD, FAAD 1 shared session
- Priyanka Ghosh, PhD 1 shared session
- Robert Lionberger FDA 1 shared session
- Roselyn E. Epps, MD, FAAD 1 shared session
Others from FDA
- Chandan Pandey HOD, Food and Drugs Administration, Mathura, UP, India 1 session